certify

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

June 6, 2021 2525 Views
The U.S. Food and Drug Administration (FDA) approved Esperion’s  NEXLETOL™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-Cholesterol ...
banner
Adsense